Prepared to OSHA, ACC, ANSI, NOHSC, WHMIS, 2001/58/EC & 1272/2008/EC Standards
MSDS Revision Date: 08/22/2012
1. PRODUCT IDENTIFICATION
Product Name:
DeoxIT® Fader F-SERIES (P/N F100L)
Chemical Name:
See ingredients listed in section 3
Synonyms:
DeoxIT® Fader F100L-L, DeoxIT® Fader F100L-H
Trade Names:
DeoxIT® Fader F100L (see list below)
Product Use:
Lubricant for conductive plastics & carbon-based controls
Manufacturer’s Name:
CAIG Laboratories, Inc.
Manufacturer’s Address:
12200 Thatcher Court, Poway, CA 92064-6876 USA
Emergency Phone:
CHEMTREC: +1 (703) 527-3887 / +1 (800) 424-3887
Business Phone:
+1 (800)-224-4123
Other Product Names:
DeoxIT® Fader F100L, 2 ml (Part No. F100L-2C, F100L-2CP); DeoxIT® Fader F100L, 2.3 ml (Part No. F100L-58D); DeoxIT® Fader F100L, 7.4 ml (Part
No. F100L-2DB); DeoxIT® Fader F100L, 12 ml (Part No. F100L-12C); DeoxIT® Fader F100L, 25 ml (Part No. F100L-25C); DeoxIT® Fader F100L, 59
ml (Part No. F100L-2); DeoxIT® Fader F100L, 236 ml (Part No. F100L-8); DeoxIT® Fader F100L, 354 ml (Part No. F100L-12); DeoxIT® Fader F100L,
472 ml (Part No. F100L-16); DeoxIT® Fader F100L, 944 ml (Part No. F100L-32); DeoxIT® Fader F100L, 30 L (Part No. F100L-8G)
Hazard Identification:
This product is classified as a HAZARDOUS SUBSTANCE but not as DANGEROUS GOODS according to the
classification criteria of NOHSC: 1008(2004) and ADG Code (Australia). DeoxIT® F100L is non-volatile, nonhazardous and non-flammable. WARNING! Causes eye irritation.
Hazard Statements (H): H320 – Causes eye irritation.
Precautionary Statements (P): P280 – Wear protective eyewear. P302 + P352 – IF ON SKIN – Wash with plenty of
soap and water. P312 – Call a Poison Control Center or doctor/physician if you feel unwell. P333 + P313 – If skin
irritation or rash occurs, get medical advise/attention. P321 – Refer to section 4 of this Safety Data Sheet (First
Aid). P305+P351+P338 – IF IN EYES - Rinse continuously with water for several minutes. Remove contact lenses if
present and easy to do – continue rinsing. P337 + P313 – If eye irritation persists, get medical advice/attention.
Effects of Exposure:
EYES: Can cause irritation, tearing, and temporary blurred vision.
SKIN: Non-irritating when used as directed. Prolonged or repeated contact may cause temporary contact dermatitis
(localized redness or rash).
INGESTION: Not probable. Small amounts if swallowed may cause temporary gastrointestinal irritation.
INHALATION: Unlikely route of exposure. Should vapor concentrations exceed recommended exposure levels, they are temporary
irritating to the eyes, nose, throat, and the respiratory tract; may cause temporary headaches and dizziness.
Symptoms of Overexposure:
EYES: Can cause temporary irritation, tearing, and blurred vision.
SKIN: Non-irritating when used as directed. Prolonged or repeated contact may cause temporary contact dermatitis
(localized redness or rash).
INGESTION: Not probable. Small amounts if swallowed may cause temporary gastrointestinal irritation.
INHALATION: Unlikely route of exposure. Should vapor concentrations exceed recommended exposure levels, they are temporary
irritating to the eyes, nose, throat, and the respiratory tract; may cause headaches and dizziness.
Acute Health Effects:
EYES: None reported when used as directed. Mild to moderate transient (temporary) irritation.
SKIN: Unlikely when used as directed. Repeated exposure at site of contact may cause temporary contact dermatitis
(localized redness or rash).
INGESTION: Not probable. Small amount may cause temporary gastrointestinal irritation and central nervous system depression.
INHALATION: Unlikely route of exposure. Should vapor concentrations exceed recommended exposure levels, they are temporary
irritating to the eyes, nose, throat, and the respiratory tract; may cause headaches and dizziness.
NA = Not Available; ND = Not Determined; NE = Not Established; C = Ceiling Limit; See Section 16 for Additional Definitions of Terms Used
NOTE: all WHMIS required information is included. It is located in appropriate sections based on the ANSI Z400.1-2010 format.
Prepared to OSHA, ACC, ANSI, NOHSC, WHMIS, 2001/58/EC & 1272/2008/EC Standards
MSDS Revision Date: 08/22/2012
2. HAZARD IDENTIFICATION (continued)
Chronic Health Effects:
None reported by the manufacturer.
3. COMPOSITION & INGREDIENT INFORMATION
EINECS No. % EXPOSURE LIMITS IN AIR (mg/m3)
First Aid:
EYES: Flush eyes thoroughly with copious amounts of water for at least 15 minutes, holding eyelid(s) open to ensure complete
flushing. If irritation persists, seek immediate medical attention.
SKIN: Remove contaminated clothing and wash affected areas with soap and water. If irritation persists, seek prompt
medical attention. Do not wear contaminated clothing until after it has been properly cleaned.
INGESTION: Do not induce vomiting! Drink plenty of water. If irritation persists, contact a physician.
INHALATION: Remove victim to fresh air at once. If breathing is difficult, administer supplemental oxygen and seek immediate
medical attention. If breathing stops, perform artificial respiration.
Medical Conditions Aggravated by Exposure:
None reported by the manufacturer.
Flashpoint & Method:
> 250 °C (482 °F)
Autoignition Temperature:
NA
Lower Explosive Limit (LEL):
Upper Explosive Limit (UEL):
Fire & Explosion Hazards:
Carbon dioxide, carbon monoxide, hydrocarbons.
Extinguishing Methods:
CO2, Alcohol foam, Dry Chemical, Water Fog
Firefighting Procedures:
Wear NIOSH/MSHA approved self-contained breathing apparatus and protective clothing. Use a water spray to
cool containers involved in fire. Do not use direct water stream. Container storage areas exposed to direct flame
contact should be cooled with large quantities of water as needed to prevent weakening of container structure.
Keep containers cool until well after the fire is out to prevent rupture. Prevent runoff from fire control or dilution
from entering sewers, drains, drinking water supply, or any natural waterway.